Maslak, Peter

Publications

Sort by

Co-Author Network

selected publications

Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia. The New England journal of medicine. 2018 Academic Article GET IT
Times cited: 1524
Single-Tube 10-Fluorochrome Analysis for Efficient Flow Cytometric Evaluation of Minimal Residual Disease in Plasma Cell Myeloma. American journal of clinical pathology. 2016 Academic Article GET IT
Times cited: 32
Comparison of manual hematocrit determinations versus automated methods for hematopoietic progenitor cell apheresis products. Transfusion. 2015 Academic Article GET IT
Times cited: 7
Evaluation of new automated hematopoietic progenitor cell analysis in the clinical management of peripheral blood stem cell collections. Transfusion. 2015 Academic Article GET IT
Times cited: 17
Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia. Science translational medicine. 2014 Academic Article GET IT
Times cited: 1836
Morphologic identification of atypical chronic lymphocytic leukemia by digital microscopy. International journal of laboratory hematology. 2013 Academic Article GET IT
Times cited: 7
Comparison of automated platelet counts and potential effect on transfusion decisions in cancer patients. American journal of clinical pathology. 2013 Academic Article GET IT
Times cited: 6
A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia. Nature genetics. 2013 Academic Article GET IT
Times cited: 224
CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia. Science translational medicine. 2013 Academic Article GET IT
Times cited: 1557
Targeting the intracellular WT1 oncogene product with a therapeutic human antibody. Science translational medicine. 2013 Academic Article GET IT
Times cited: 137
Treatment of adults with acute lymphoblastic leukemia: do the specifics of the regimen matter?: Results from a prospective randomized trial. Cancer. 2012 Academic Article GET IT
Times cited: 14
Translocation t(11;17) in de novo myelodysplastic syndrome not associated with acute myeloid or acute promyelocytic leukemia. 2012 GET IT
Times cited: 3
Acute myeloid leukemia with translocation t(8;16) presents with features which mimic acute promyelocytic leukemia and is associated with poor prognosis. Leukemia research. 2012 Academic Article GET IT
Times cited: 27
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias. Blood. 2011 Academic Article GET IT
Times cited: 1031
Acute myeloid leukemia. 2011 GET IT
Times cited: 48
WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer. Cancer immunology, immunotherapy : CII. 2010 Academic Article GET IT
Times cited: 102
Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia. Blood. 2010 Academic Article GET IT
Times cited: 131
Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: molecular remissions predict for durable complete responses. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Academic Article GET IT
Times cited: 62
Acute myeloid leukemia. Journal of the National Comprehensive Cancer Network : JNCCN. 2008 Review GET IT
Times cited: 9
Strategy for incorporating molecular and cytogenetic markers into acute myeloid leukemia therapy. Journal of the National Comprehensive Cancer Network : JNCCN. 2008 Review GET IT
Times cited: 3
Azacitidine and the beginnings of therapeutic epigenetic modulation. Expert opinion on pharmacotherapy. 2008 Review GET IT
Times cited: 21
A pilot vaccination trial of synthetic analog peptides derived from the BCR-ABL breakpoints in CML patients with minimal disease. Leukemia. 2008 Letter GET IT
Times cited: 38
Tolerability, pharmacodynamics, and pharmacokinetics studies of depsipeptide (romidepsin) in patients with acute myelogenous leukemia or advanced myelodysplastic syndromes. Clinical cancer research : an official journal of the American Association for Cancer Research. 2008 Academic Article GET IT
Times cited: 127
CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy. Blood. 2008 Academic Article GET IT
Times cited: 37
Diagnosis and treatment of acute promyelocytic leukemia. Current oncology reports. 2007 Review GET IT
Times cited: 37
Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Academic Article GET IT
Times cited: 73
Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Academic Article GET IT
Times cited: 304
Monoclonal antibody therapy of APL. Current topics in microbiology and immunology. 2007 Review GET IT
Times cited: 3
Grading follicular lymphomas in fine-needle aspiration biopsies: the role of ThinPrep slides and flow cytometry. Cancer. 2006 Academic Article GET IT
Times cited: 23
Acanthocytes. Blood. 2006 Academic Article GET IT
Pegylated interferon plus rituximab in advanced stage, indolent lymphoma: is there CD20 antigen upregulation?. Leukemia & lymphoma. 2006 Academic Article GET IT
Times cited: 11
Antibody-drug conjugates in acute myeloid leukemia. Nature clinical practice. Oncology. 2006 Academic Article GET IT
Times cited: 1
Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Academic Article GET IT
Times cited: 142
Pilot study of combination transcriptional modulation therapy with sodium phenylbutyrate and 5-azacytidine in patients with acute myeloid leukemia or myelodysplastic syndrome. Leukemia. 2006 Academic Article GET IT
Times cited: 102
Acute myeloid leukemia clinical practice guidelines in oncology. 2006 GET IT
Times cited: 20
Rhabdomyosarcoma. Blood. 2005 Academic Article GET IT
Times cited: 1
Therapy of acute promyelocytic leukemia. Advances in pharmacology (San Diego, Calif.). 2004 Review GET IT
Times cited: 4
Pentostatin and cyclophosphamide: an effective new regimen in previously treated patients with chronic lymphocytic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Academic Article GET IT
Times cited: 92
Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin. Cancer. 2003 Academic Article GET IT
Times cited: 233
Clinical applications of molecular monitoring in leukemia. Current hematology reports. 2003 Review GET IT
Times cited: 2
A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia. Cancer. 2002 Academic Article GET IT
Times cited: 26
Phase I study of the cyclin-dependent kinase inhibitor flavopiridol in combination with paclitaxel in patients with advanced solid tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Academic Article GET IT
Times cited: 147
Acute myeloid leukemia with t(5;18)(q35;q21). 2001 GET IT
Times cited: 5
Clonotypic polymerase chain reaction confirms minimal residual disease in CLL nodular PR: results from a sequential treatment CLL protocol. Blood. 2001 Academic Article GET IT
Times cited: 26
Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Academic Article GET IT
Times cited: 201
NCCN Practice Guidelines for Acute Myelogenous Leukemia. 2000 GET IT
Times cited: 25
Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy. Leukemia. 2000 Academic Article GET IT
Times cited: 40
Targeted therapies for the myeloid leukaemias. Expert opinion on investigational drugs. 2000 Review GET IT
Times cited: 13
Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. The New England journal of medicine. 1998 Academic Article GET IT
Times cited: 1112
The efficacy of IL-3, SCF, IL-6, and IL-11 in treating thrombocytopenia. Seminars in hematology. 1998 Review GET IT
Times cited: 16
A phase I trial of a single high dose of idarubicin combined with high-dose cytarabine as induction therapy in relapsed or refractory adult patients with acute lymphoblastic leukemia. Leukemia. 1998 Academic Article GET IT
Times cited: 16
Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 1998 Academic Article GET IT
Times cited: 121
Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells. Clinical cancer research : an official journal of the American Association for Cancer Research. 1997 Academic Article GET IT
Times cited: 120
NCCN Acute Leukemia Practice Guidelines. The National Comprehensive Cancer Network. 1996 GET IT
Times cited: 5
Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
Times cited: 62
Pilot study of 5-azacytidine (5-AZA) and carboplatin (CBDCA) in patients with relapsed/refractory leukemia. American journal of hematology. 1996 Academic Article GET IT
Times cited: 9
Granulocyte colony-stimulating factor following chemotherapy in elderly patients with newly diagnosed acute myelogenous leukemia. Leukemia. 1996 Academic Article GET IT
Times cited: 23
Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells. Journal of the National Cancer Institute. 1995 Academic Article GET IT
Times cited: 110
The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents. International journal of cancer. 1995 Academic Article GET IT
Times cited: 94
Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195. Leukemia. 1995 Academic Article GET IT
Times cited: 45
Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid. Blood. 1994 Review GET IT
Times cited: 267
Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia. Cytometry. 1994 Academic Article GET IT
Times cited: 38
Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experience. Leukemia. 1994 Academic Article GET IT
Times cited: 81
Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experience. Leukemia. 1994 Academic Article GET IT
Times cited: 59
Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1993 Academic Article GET IT
Times cited: 116
CD2 expression and PML/RAR-alpha transcripts in acute promyelocytic leukemia. Blood. 1993 Letter GET IT
Times cited: 17
Acute lymphoblastic leukemia: present and future. Leukemia. 1992 Review GET IT
Successful removal of a curled central venous catheter using interventional radiologic techniques. 1992 GET IT

more ...

less ...

Background

education and training

M.D., Mount Sinai School of Medicine 1984
A.B., Columbia University 1980

Contact

full name

Peter Maslak

VIVO Weill Cornell Medical College

Peter Maslak Professor of Clinical Medicine

Publications

selected publications

Background

education and training

Contact

full name

Phone

Publications

selected publications

Background

education and training

Contact

full name